Lucile Warter

947 total citations
21 papers, 688 citations indexed

About

Lucile Warter is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lucile Warter has authored 21 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Epidemiology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lucile Warter's work include Mosquito-borne diseases and control (11 papers), Viral Infections and Vectors (9 papers) and Hepatitis C virus research (6 papers). Lucile Warter is often cited by papers focused on Mosquito-borne diseases and control (11 papers), Viral Infections and Vectors (9 papers) and Hepatitis C virus research (6 papers). Lucile Warter collaborates with scholars based in United States, Belgium and France. Lucile Warter's co-authors include Cheng‐I Wang, Jan Frič, Alessandra Nardin, Sébastien Bertin-Maghit, Annette Martin, Yann Bénureau, Chia Yin Lee, Lisa F. P. Ng, Laurent Rénia and Esther G. L. Koh and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Lucile Warter

20 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lucile Warter United States	12	425	360	184	161	103	21	688
Claire Hutchings United Kingdom	17	261 0.6×	192 0.5×	361 2.0×	262 1.6×	271 2.6×	28	905
Vera Buerger Austria	8	191 0.4×	198 0.6×	83 0.5×	233 1.4×	88 0.9×	12	488
Laure Juompan United States	10	299 0.7×	160 0.4×	250 1.4×	121 0.8×	145 1.4×	14	615
Heather Friberg United States	15	499 1.2×	464 1.3×	126 0.7×	73 0.5×	77 0.7×	43	699
Trevor Barnes United States	9	337 0.8×	392 1.1×	53 0.3×	240 1.5×	109 1.1×	10	637
Sylvester Daniel United States	11	172 0.4×	211 0.6×	173 0.9×	158 1.0×	36 0.3×	16	465
Kenn Forberg United States	10	186 0.4×	136 0.4×	94 0.5×	165 1.0×	45 0.4×	19	426
Clarisse Lorin Belgium	14	167 0.4×	341 0.9×	196 1.1×	398 2.5×	174 1.7×	20	775
Andrew S. Kondratowicz United States	12	167 0.4×	592 1.6×	183 1.0×	267 1.7×	203 2.0×	13	927
Laurie R. Gray United States	13	458 1.1×	127 0.4×	195 1.1×	81 0.5×	118 1.1×	21	725

Countries citing papers authored by Lucile Warter

Since Specialization

Citations

This map shows the geographic impact of Lucile Warter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucile Warter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucile Warter more than expected).

Fields of papers citing papers by Lucile Warter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucile Warter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucile Warter. The network helps show where Lucile Warter may publish in the future.

Co-authorship network of co-authors of Lucile Warter

This figure shows the co-authorship network connecting the top 25 collaborators of Lucile Warter. A scholar is included among the top collaborators of Lucile Warter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucile Warter. Lucile Warter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Alison, Dexter Wiseman, Corinne Vandermeulen, et al.. (2025). Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review. Expert Review of Clinical Immunology. 21(6). 745–760.

Roman, François, Wivine Burny, Maria Angeles Ceregido, et al.. (2024). Adjuvant system AS01: from mode of action to effective vaccines. Expert Review of Vaccines. 23(1). 715–729. 26 indexed citations

Genito, Christopher J., Alexis A. Smith, Emma Ryan, et al.. (2023). Protective antibody threshold of RTS,S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model. npj Vaccines. 8(1). 114–114. 5 indexed citations

Smedt, Jonathan De, Vera Rocha‐Perugini, Edison Ong, et al.. (2023). The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains. Science Translational Medicine. 15(710). eadg6050–eadg6050. 16 indexed citations

Warter, Lucile, et al.. (2023). Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models. npj Vaccines. 8(1). 143–143. 10 indexed citations

McCracken, Michael K., Gregory D. Gromowski, Lindsey S. Garver, et al.. (2020). Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques. PLoS neglected tropical diseases. 14(4). e0008191–e0008191. 19 indexed citations

Lorin, Clarisse, et al.. (2020). A new therapeutic candidate vaccine can overcome hepatitis B virus-induced immune tolerance in a mouse model of chronic infection. Journal of Hepatology. 73. S571–S571. 2 indexed citations

Marchevsky, Renato Sérgio, Leonardo Diniz‐Mendes, Marcos S. Freire, et al.. (2019). Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines. PLoS Pathogens. 15(4). e1007721–e1007721. 23 indexed citations

Marchevsky, Renato Sérgio, Ana María Bispo de Filippis, Pedro Fernando da Costa Vasconcelos, et al.. (2018). Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques. PLoS ONE. 13(4). e0196311–e0196311. 7 indexed citations

10.

Fernandez, Stefan, Stephen J. Thomas, Rafael De La Barrera, et al.. (2015). An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques. American Journal of Tropical Medicine and Hygiene. 92(4). 698–708. 49 indexed citations

11.

Frič, Jan, Sébastien Bertin-Maghit, Cheng‐I Wang, Alessandra Nardin, & Lucile Warter. (2012). Use of Human Monoclonal Antibodies to Treat Chikungunya Virus Infection. The Journal of Infectious Diseases. 207(2). 319–322. 63 indexed citations

12.

Warter, Lucile, Ramapraba Appanna, & Katja Fink. (2012). Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology. Immunologic Research. 53(1-3). 148–161. 19 indexed citations

13.

Xu, Meihui, Ramapraba Appanna, Ying Xiu Toh, et al.. (2012). Plasmablasts Generated during Repeated Dengue Infection Are Virus Glycoprotein–Specific and Bind to Multiple Virus Serotypes. The Journal of Immunology. 189(12). 5877–5885. 51 indexed citations

14.

Lee, Chia Yin, Yiu‐Wing Kam, Jan Frič, et al.. (2011). Chikungunya Virus Neutralization Antigens and Direct Cell-to-Cell Transmission Are Revealed by Human Antibody-Escape Mutants. PLoS Pathogens. 7(12). e1002390–e1002390. 83 indexed citations

15.

Russell, Bruce, Rossarin Suwanarusk, Céline Borlon, et al.. (2011). A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood. 118(13). e74–e81. 102 indexed citations

16.

Warter, Lucile, Chia Yin Lee, Marc Grandadam, et al.. (2011). Chikungunya Virus Envelope-Specific Human Monoclonal Antibodies with Broad Neutralization Potency. The Journal of Immunology. 186(5). 3258–3264. 75 indexed citations

17.

Bénureau, Yann, Lucile Warter, Bruce A. Malcolm, & Annette Martin. (2010). A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication. Virology. 406(2). 228–240. 6 indexed citations

18.

Warter, Lucile, Yann Bénureau, Deborah Chavez, et al.. (2009). A Cooperative Interaction between Nontranslated RNA Sequences and NS5A Protein Promotes In Vivo Fitness of a Chimeric Hepatitis C/GB Virus B. PLoS ONE. 4(2). e4419–e4419. 10 indexed citations

19.

Mankouri, Jamel, et al.. (2008). A comparative cell biological analysis reveals only limited functional homology between the NS5A proteins of hepatitis C virus and GB virus B. Journal of General Virology. 89(8). 1911–1920. 4 indexed citations

20.

Chen, Zihong, Yann Bénureau, René Rijnbrand, et al.. (2006). GB Virus B Disrupts RIG-I Signaling by NS3/4A-Mediated Cleavage of the Adaptor Protein MAVS. Journal of Virology. 81(2). 964–976. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact